Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

VECTOR: First Percutaneous Aorto-Coronary Bypass Case, a New Conceptual Approach

Coronary obstruction represents one of the most severe complications associated with transcatheter aortic valve implantation, particularly in valve-in-valve scenarios involving surgical bioprostheses, narrow aortic sinuses, low coronary ostia, and severely calcified leaflets. In this setting, several preventive strategies have been developed over recent years, including BASILICA, UNICORN, CATHEDRAL, and snorkel stenting. However, these complex techniques may be unfeasible in the presence of specific anatomical limitations.

Bruce et al., from Emory University Hospital (Atlanta, USA), described the first-in-human case of an extra-anatomical percutaneous aorto-coronary bypass, termed VECTOR (Ventriculo-Coronary Transcatheter Outward Navigation and Re-entry), developed with the specific aim of preventing left main coronary artery obstruction during transcatheter valve implantation. This approach introduces a relevant conceptual shift, as it does not seek to modify the valve or protect the native coronary ostium, but rather to functionally relocate coronary blood flow through the creation of a new percutaneous pathway.

The procedure was performed in a 67-year-old patient with severe degeneration of a surgical aortic bioprosthesis (25 mm Magna Ease), a history of prior mitral valve replacement (29 mm Epic, degenerated and treated with valve-in-valve using Sapien 3 Ultra), advanced ventricular dysfunction, and multiple comorbidities rendering the patient prohibitive for conventional surgery, with a Society of Thoracic Surgeons–predicted operative mortality of 13%. Computed tomography planning demonstrated an extreme risk of coronary obstruction, with critically short valve-to-coronary distances and confluent leaflet calcification, thereby excluding any leaflet modification strategy. The procedure was performed under general anesthesia with venoarterial extracorporeal membrane oxygenation support.

Read also: Comparison of strategies: NMA of IVUS, OCT, or angiography in complex lesions.

VECTOR in TAVI: effective coronary perfusion through a percutaneous bypass

From a technical standpoint, the strategy combined transcatheter electrosurgery with advanced concepts derived from chronic total occlusion recanalization. The procedure consisted of creating an extra-anatomical bypass between the aorta and the left main coronary artery using covered stents. The distal anastomosis was achieved through intentional exit from the left main coronary artery into the pericardial space, assisted by stent-and-stingray–type techniques. This involved aorto-venous externalization through septal perforation and capture in the right ventricle with a snare, followed by retrograde advancement of a dual-lumen microcatheter to access the pericardial space. The proximal anastomosis was performed by electro-surgical exit from the aorta into the pericardial space and retrograde advancement of the coronary guidewire toward the pericardial guiding catheter. The resulting graft, composed of two overlapping PK Papyrus stents, provided adequate coronary perfusion with functional exclusion of the native ostium.

Following bypass creation, valve implantation was performed, resulting in compression of the anchoring stent at the native ostium due to displacement of the surgical leaflet. Follow-up imaging at six months confirmed graft patency and occlusion of the native left main coronary artery between the transcatheter valve and the distal anastomosis. The patient demonstrated a favorable clinical course during follow-up.

Read also: Dynamic Coronary Roadmap: does it really help reduce contrast use?

Conclusion: VECTOR expands the structural interventional approach in TAVI

This first-in-human report demonstrates the feasibility of a fully percutaneous aorto-coronary bypass as a preventive strategy against coronary obstruction in patients without surgical alternatives. Beyond its technical complexity, VECTOR expands the conceptual spectrum of structural intervention by showing that, in highly selected cases, the solution may lie in redefining the coronary blood flow pathway through a percutaneous approach.

Original Title: Percutaneous Aorto-Coronary Bypass Graft to Prevent Coronary Obstruction Following TAVR: First Human VECTOR Procedure.

Reference: Bruce CG, Babaliaros VC, Paone G, Gleason PT, Halaby RN, Khan JM, Rogers T, Richter E, Lederman RJ, Greenbaum AB. Percutaneous Aorto-Coronary Bypass Graft to Prevent Coronary Obstruction Following TAVR: First Human VECTOR Procedure. Circ Cardiovasc Interv. 2026 Jan 6:e016130. doi: 10.1161/CIRCINTERVENTIONS.125.016130. Epub ahead of print. PMID: 41492768; PMCID: PMC12778967.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

Beyond TAVI: Cardiac Rehabilitation as a Determinant of Clinical Outcomes

Aortic stenosis is an increasingly prevalent condition associated with population aging, with a prevalence of approximately 3.4% in individuals over 75 years of age...

Comparative outcomes between transaxillary approach and thoracotomy-based approaches in TAVI with alternative access

TAVI has become the standard treatment for high-risk aortic stenosis. When transfemoral access is not feasible (approximately 10–15%), alternative approaches are used: transaxillary (subclavian...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...